April 2012 Issue

IN THIS ISSUE:     PRINT VERSION


  • New Once Weekly Treatment Option For Type 2 Diabetes
  • Nursing Consideration for the Patient Taking Anxiolytics
  • Multi-dose vials
  • FDA NEWS RELEASE: FDA Announces Safety Changes In Labeling For Some Cholesterol-Lowering Drugs

Multi-Dose Vials

Administering parenteral medications has become routine for nurses across the healthcare spectrum. Subcutaneous, intramuscular, intravenous, or intradermal routes all provide medications in a specific manner. These medications are dispensed in vials, some of which are single use, others multi-dose. Read More

FDA News Release

FDA Announces Safety Changes In Labeling For Some Cholesterol-Lowering Drugs Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins are being announced today by the U.S. Food and Drug Administration. Read More

New Once Weekly Treatment Option for Type 2 diabetes

The FDA has approved an extended release form of Byetta, under the brand name Bydureon. It is the first ever once weekly treatment for type 2 diabetes. Read More

Nursing Consideration for the Patient Taking Anxiolytics

Some patients suffer from anxiety, an unpleasant experience. This is an emotional state defined by  psychological and physiological responses to the anticipation of real or imagined danger. Read More